Medytox, South Korea’s leading producer of botulinum toxin products, set up a joint venture firm MedyCeles with Celeste (Thailand) Co Ltd to strengthen its business in Southeast Asia, according to a report in The Korea Herald, last week.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
